Travere Therapeutics
TVTX
TVTX
135 hedge funds and large institutions have $900M invested in Travere Therapeutics in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 43 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-14
Holders Change %
-9.4%
% of All Funds
2.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
49
Reduced
43
Closed
36
Calls
$2.43M
Puts
$1.99M
Net Calls
+$432K
Net Calls Change
+$122K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$49.5M |
| 2 |
Goldman Sachs
New York
|
+$23.8M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$17.1M |
| 4 |
JPMorgan Chase & Co
New York
|
+$15M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.8M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$40.2M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$31.2M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$23.3M |
| 4 |
PA
Perceptive Advisors
New York
|
-$21.2M |
| 5 |
HM
HealthCor Management
New York
|
-$15.4M |
